BRETEC — Bioretec Oy Cashflow Statement
0.000.00%
Last trade - 00:00- €54.30m
- €48.06m
- €3.91m
Annual cashflow statement for Bioretec Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | FAS | FAS | FAS | FAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | — | -6.02 | -2.42 | — |
| Depreciation | |||||
| Non-Cash Items | — | — | 3.35 | 0.125 | -0.006 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.22 | -2 | 0.11 | -0.248 | -3.43 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.22 | -2 | -2.39 | -2.36 | -3.44 |
| Capital Expenditures | — | — | -0.393 | -0.26 | -0.161 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.055 | -0.121 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.055 | -0.121 | -0.393 | -0.26 | -0.161 |
| Financing Cash Flow Items | 0.099 | 4.33 | -1.79 | -1.51 | -0.775 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.099 | 4.33 | 7.13 | -2.78 | 9.29 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.17 | 2.22 | 4.35 | -5.4 | 5.69 |